A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)
CLN-978-RA-101
Phase 1 other active
Quick answer
A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA) for Treatment-Refractory Rheumatoid Arthritis is a Phase 1 program (other) at Cullinan Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cullinan Therapeutics
- Indication
- Treatment-Refractory Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- other
- Status
- active